(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane

C39H61N5O9 — CID 158545240

IUPAC(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane
SMILESC.CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)C(N(C)C)C2O)[C@@H](CCn2cc(-c3ccncc3)nn2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO
InChIInChI=1S/C38H57N5O9.CH4/c1-8-32-28(21-44)17-22(2)9-10-30(45)23(3)18-27(13-16-43-20-29(40-41-43)26-11-14-39-15-12-26)37(24(4)31(46)19-33(47)51-32)52-38-36(49)34(42(6)7)35(48)25(5)50-38;/h9-12,14-15,17,20,23-25,27-28,31-32,34-38,44,46,48-49H,8,13,16,18-19,21H2,1-7H3;1H4/b10-9+,22-17+;/t23-,24+,25-,27+,28-,31-,32-,34?,35-,36?,37-,38+;/m1./s1
InChIKeyHPAKMLDIAOGUSM-QWRCTEQHSA-N
MW743.94 g/mol
LogP3.19
Rot. Bonds9

About (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane

(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane (PubChem CID 158545240) has the molecular formula C39H61N5O9 and a molecular weight of 743.94 g/mol. Its IUPAC name is (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane.

Molecular Properties

Compound Name(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane
PubChem CID158545240
Molecular FormulaC39H61N5O9
Molecular Weight743.94 g/mol
Exact Mass743.45
IUPAC Name(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane
SMILESC.CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)C(N(C)C)C2O)[C@@H](CCn2cc(-c3ccncc3)nn2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO
InChIInChI=1S/C38H57N5O9.CH4/c1-8-32-28(21-44)17-22(2)9-10-30(45)23(3)18-27(13-16-43-20-29(40-41-43)26-11-14-39-15-12-26)37(24(4)31(46)19-33(47)51-32)52-38-36(49)34(42(6)7)35(48)25(5)50-38;/h9-12,14-15,17,20,23-25,27-28,31-32,34-38,44,46,48-49H,8,13,16,18-19,21H2,1-7H3;1H4/b10-9+,22-17+;/t23-,24+,25-,27+,28-,31-,32-,34?,35-,36?,37-,38+;/m1./s1
InChIKeyHPAKMLDIAOGUSM-QWRCTEQHSA-N
XLogP3.19
TPSA189.59 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds9
Heavy Atoms53
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500743.94
LogP ≤ 53.19
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Analyze (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane?
The IUPAC name of (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane (CID 158545240) is (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane.
What is the SMILES notation for (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane?
The canonical SMILES for (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane is C.CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)C(N(C)C)C2O)[C@@H](CCn2cc(-c3ccncc3)nn2)C[C@@H](C)C(=O)/C=C/C(C)=C/[C@@H]1CO.
What is the InChIKey of (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane?
The InChIKey is HPAKMLDIAOGUSM-QWRCTEQHSA-N. The full InChI is InChI=1S/C38H57N5O9.CH4/c1-8-32-28(21-44)17-22(2)9-10-30(45)23(3)18-27(13-16-43-20-29(40-41-43)26-11-14-39-15-12-26)37(24(4)31(46)19-33(47)51-32)52-38-36(49)34(42(6)7)35(48)25(5)50-38;/h9-12,14-15,17,20,23-25,27-28,31-32,34-38,44,46,48-49H,8,13,16,18-19,21H2,1-7H3;1H4/b10-9+,22-17+;/t23-,24+,25-,27+,28-,31-,32-,34?,35-,36?,37-,38+;/m1./s1.
What are the key properties of (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane?
(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane has a molecular weight of 743.94 g/mol, XLogP of 3.19, 9 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-7-[2-(4-pyridin-4-yltriazol-1-yl)ethyl]-1-oxacyclohexadeca-11,13-diene-2,10-dione;methane is sourced from PubChem (CID 158545240), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).